Statement of Changes of Beneficial Ownership


FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HERRICK ALAN J
2. Issuer Name and Ticker or Trading Symbol

SAPIENT CORP [ SAPE ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chief Executive Officer
(Last)          (First)          (Middle)

C/O SAPIENT CORPORATION, 131 DARTMOUTH STREET
3. Date of Earliest Transaction (MM/DD/YYYY)

1/1/2012
(Street)

BOSTON, MA 02116
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   1/1/2012     F    17701   D $12.6   803220   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  409,570 of these securities are units of common stock granted pursuant to restricted stock unit awards. The units are subject to time-based vesting.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HERRICK ALAN J
C/O SAPIENT CORPORATION
131 DARTMOUTH STREET
BOSTON, MA 02116
X
Chief Executive Officer

Signatures
/s/ Kimberly C. Nuzum, as Attorney-in-Fact for Alan J. Herrick 1/4/2012
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
POWER OF ATTORNEY
For Executing Forms 3, 4 and 5

The undersigned hereby constitutes and appoints each of Joseph A. LaSala, Esq.,
Kimberly C. Nuzum, Esq. and Laurie A. Cerveny, Esq. as his or her true and
lawful attorneys-in-fact to:

1.  execute for and on behalf of the undersigned Forms 3, 4 and 5 relating to
changes in the undersigned's beneficial ownership of securities of Sapient
Corporation and any necessary amendments to such forms, in accordance with
Section 16(a) of the Securities Exchange Act of 1934 (as amended, the
"1934 Act") and the rules thereunder, and

2.  do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete the execution of any such Forms 3, 4
or 5 and the timely filing of such forms with the Securities and Exchange
Commission and any other governmental authority.

The undersigned hereby grants to such attorneys-in-fact full power and authority
to do and perform every act necessary and proper in the exercise of any of the
rights and powers herein granted, as fully as such
attorneys-in-fact could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorneys-in-fact shall lawfully do or cause to be done by virtue of
this Power of Attorney and the rights and powers herein granted.  The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are not assuming
any of the undersigned's liabilities under Section 16 of the 1934 Act.

This Power of Attorney is effective as of August 23, 2011 (the "Effective
Date"), and upon the Effective Date, shall replace any previous Powers of
Attorney signed by the undersigned with respect to the matters
covered above and shall remain in effect for so long as the undersigned is
required to file reports under Section 16(a) of the 1934 Act with respect to
securities of Sapient Corporation.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 16th day of August, 2011.


/s/ Alan J. Herrick
Alan J. Herrick